We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current AGE market cap is 421.26M. The company's latest EPS is USD -0.2936 and P/E is -20.16.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 56k | 5k | 51k | 14k | -14k |
| Operating Income | -3.56M | -2.32M | -3.87M | -5.31M | -5.55M |
| Net Income | -3.46M | -9.44M | -374k | 1.41M | -2.74M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.87M | 144k | 34k | 142k | 56k |
| Operating Income | -10.67M | -8.04M | -6.98M | -9.96M | -17.05M |
| Net Income | -10.87M | -8.68M | -10.46M | -14.8M | -11.14M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 11.97M | 10.86M | 10.71M | 7.44M | 6.72M |
| Total Liabilities | 6.61M | 15.17M | 27.1M | 21.26M | 6.22M |
| Total Equity | 5.36M | -4.31M | -16.39M | -13.83M | 508k |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 3.93M | 3.15M | 3.24M | 11.97M | 6.72M |
| Total Liabilities | 9.32M | 15.03M | 20.56M | 6.61M | 6.22M |
| Total Equity | -5.4M | -11.88M | -17.32M | 5.36M | 508k |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -7.8M | -1.58M | -9.59M | -12.55M | -17.14M |
| Investing | -10M | -14k | -14k | -17k | -22k |
| Financing | 17.5M | 2.73M | 8.1M | 8.18M | 13.21M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -7.82M | -7.86M | -5.94M | -7.8M | -17.14M |
| Investing | -20k | 666k | N/A | -10M | -22k |
| Financing | 5.96M | 7.25M | 6M | 17.5M | 13.21M |
| Market Cap | 421.26M |
| Price to Earnings Ratio | -20.16 |
| Price to Sales Ratio | 3.95k |
| Price to Cash Ratio | 61.16 |
| Price to Book Ratio | 442.27 |
| Dividend Yield | - |
| Shares Outstanding | 37.95M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 12.54 (65.31%) |
| Company Name | AgeX Therapeutics Inc |
| Address |
108 lakeland ave dover, delaware 19901 |
| Website | https://serinatherapeutics.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
